Itacitinib for the Prevention of Immune Effector Cell Therapy-Associated Cytokine Release Syndrome: Results from the Phase 2 Incb 39110-211 Placebo-Controlled Randomized CohortMatthew J. Frigault,Richard T Maziarz,Jae H. Park,Aleksandr Lazaryan,Nirav N. Shah,Jakub Svoboda,Lazaros J. Lekakis,Ran Reshef,Christine L Phillips,Lea M Burke, Jing Lei,Rodica Morariu-Zamfir,John F. DiPersioBlood（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
